SCHEMBL15909027

SCHEMBL15909027

O=C(OCc1cc(=O)n2nc(-c3ccc(Cl)cc3)c(-c3cccs3)c2[nH]1)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 13/20 0.41
MAPT P10636 11/20 0.41
MAPK14 Q16539 1/20 0.37
RXFP1 Q9HBX9 4/20 0.34
LMNA P02545 2/20 0.33
ARF6 P62330 2/20 0.33
THRB P10828 1/20 0.33
FABP3 P05413 1/20 0.33
FABP4 P15090 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRA4 P48169 1/20 0.33
GABRA6 Q16445 1/20 0.33
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15909266 0.87 ARF6 (0.39) MAPTLMNAARF6TDP1
SCHEMBL1615068 0.85 MAPK14 (0.37) POLBMAPTMAPK14LMNAARF6
SCHEMBL15909113 0.84 POLB (0.36) POLBMAPTRXFP1LMNATHRB
SCHEMBL15926321 0.84 MAPK14 (0.40) POLBMAPTMAPK14RXFP1LMNA
SCHEMBL1279271 0.83 MAPK14 (0.41) POLBMAPTMAPK14RXFP1LMNA
SCHEMBL1279158 0.80 ADORA3 (0.39) POLBMAPTMAPK14ARF6GRIN1
SCHEMBL15909132 0.76 ARF6 (0.36) MAPTLMNAARF6
SCHEMBL1614861 0.74 ARF6 (0.39) MAPTARF6TDP1
SCHEMBL1614869 0.72 MAPT (0.38) POLBMAPTLMNATHRBTDP1
SCHEMBL15908924 0.72 ARF6 (0.42) POLBLMNAARF6L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed